A retrospective study about the efficacy of PA/A ratio as a prognostic factor for Stage0-I non-small cell lung cancer

A retrospective study about the efficacy of PA/A ratio as a prognostic factor for Stage0-I non-small cell lung cancer - A retrospective study about the efficacy of PA/A ratio as a prognostic factor for Stage0-I non-small cell lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054414

Enrollment

300

Registered

2024-05-16

Start date

2024-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent complete resection for pathological Tis-1cN0M0 NSCLC between January 2013 and December 2018.

Exclusion criteria

Exclusion criteria: Patients with receiving induction therapy, previous lung resection, or the presence of simultaneous or metachronous cancers.

Design outcomes

Primary

Measure	Time frame
overall survival	—

Countries

Japan

Contacts

Public ContactMegumi Nishikubo

Hyogo Cancer Center Division of chest surgery

megumis0512@gmail.com+81-78-929-1151

Outcome results